Fig. 2From: Diagnostic utility of next-generation sequencing-based panel testing in 543 patients with suspected skeletal dysplasiaDiagnostic yield of next-generations sequencing-based multi-gene panel tests for suspected skeletal dysplasia by age at time of testingBack to article page